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Abstract
Objectives The primary aim of this study is to perform an
internal quality control of pediatric brain tumor surgery in
the neurosurgical department of the VU University Medical
Center Amsterdam (The Netherlands). Secondly, this study
aims to contribute to the accumulating data concerning
outcome in pediatric neurosurgery, in order to establish
institutional practice benchmarks.
Methods We report the surgical mortality and morbidity of
121 patients (0–18 years) surgically treated for a brain tumor
from January 1999 to August 2007. Patients, in whom only a
brain tumor biopsy was performed, were excluded.
Results Mean age at first surgery was 8.2 years. Of the 121
patients, 14 had a second surgery, and two underwent a
third surgery (for a total of 137 operations). Of all 121
primary surgeries, 66% were total resections, 26% subtotal
resections, and 8% partial resections. The overall surgical
morbidity rate in this study was 69% after first surgery,
50% after second surgery, and one out of two after third
surgery.
Conclusion These overall morbidity rates are comparable
to other published mixed case series. The surgical mortality
rate was 0.8%; this is comparable to the lowest rates reported
for high-volume neurosurgical centers. We encourage other
neurosurgical centers to collect, analyze, and publish their
data. These data can then serve as a basis for comparison with
other pediatric neurosurgical centers and will eventually lead
to an improvement of pediatric neurosurgical practice and
patient care.
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Objective
Nowadays, quality control of medical care is becoming
increasingly more important. In hospitals, departments are
required to meet certain quality standards, and internal
auditing is an instrument that can be used to obtain
treatment outcome data. Transparent publication of these
performance data is also expected by external stakeholders.
For surgical specialties, these data do not only give an
indication of the quality of care and accurate information
about operative risks but also allow for the analysis of
factors to improve patient care and for comparison of the
results with those of other surgeons and institutions [2].
Outcome indicators of patient care are hardly available in
pediatric neurosurgery, particularly in the Netherlands.
Brain tumors are the second most common malignancy
to occur during childhood. Surgical resection, as a first step
in the multidisciplinary treatment, remains the mainstay of
treatment [5, 10, 17, 20, 22]. Outcome analysis for this kind
of surgical procedure is complex, but relatively easy to
define parameters are postoperative mortality and morbidity,
of which some data have now been published. Usually, these
data pertain to single tumor entities, such as medulloblas-
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tomas, brain stem tumors, or ependymomas. However,
outcome data on mixed tumor case series have not been
reported frequently, whereas for most centers treating
children with brain tumors, these data may be more
pertinent to compare to than the outcome data on single
tumor entities, which are often derived from renowned,
large pediatric neurosurgical centers, which are not readily
accessible for most patients around the world [1, 3, 19, 22].
The aim of this study was to perform an internal
quality control of the pediatric neurosurgical department
of the VU University medical center (VUmc) Amsterdam
(The Netherlands), a tertiary referral center for children
with brain tumors, and to relate the data to published
international outcomes. This way, we hope to contribute
to the outcome data concerning pediatric neurosurgery
and to establish institutional practice benchmarks for
smaller, less specialized centers.
Methods
Between January 1999 and August 2007, 149 children were
surgically treated for an intracranial neoplasm at the VUmc
(Amsterdam, the Netherlands). All patients were younger
than 18 years at the time of first surgery. Patients, in whom
only a brain tumor biopsy (n=28) was performed, were
excluded. In the remaining 121 children, 137 craniotomies
were performed. All data were collected by retrospectively
reviewing patient medical records. In those cases where the
medical records were incomplete, additional information was
collected from the Medical Administration’s Office or from
local hospitals. All patients were examined in detail, pre- and
postoperatively, by pediatricians, pediatric neurologists, and
neurosurgeons, and all patients had previously undergone a
complete investigative work-up with computed tomography
(CT), magnetic resonance (MR) scan, or both.
Surgical techniques included image-guided microsurgery,
ultrasonic aspiration, ultrasound tumor localization, and
cortical mapping, with the individual cases dictating the
techniques required. Each surgical procedure was attended by
one of the senior pediatric neurosurgeons. The objectives of
surgery were maximal possible resection of the tumor with
optimal neurological outcome. The radicality of the resection
was determined by postoperative CT or MR scans, or in lack
thereof, estimated by analyzing the surgeon’s estimate as
described in surgical reports. The extent of tumor resection for
each patient was graded as follows: complete resection (no
residual tumor on postoperative neuroimaging or highly
probable surgeon’s estimation), subtotal (more than 80%
resection), and partial (less than 80% resection). The cause for
partial removal was retrieved from the operative reports and
was classified as either due to the tumor’s pathology/anatomy,
technical reasons, or a combination of these.
Each type of tumor was graded and specified according
to the 2007 WHO classification [11]. The tumor locations
were divided into eight categories: supratentorial/right or
left hemisphere/ventricle, cerebellum, brain stem, fourth
ventricle, sellar/suprasellar/third ventricle, thalamus/basal
nuclei, cerebellopontine angle, and pineal gland.
The histopathological diagnosis and age determined
which adjuvant therapies, such as radiotherapy and chemo-
therapy, were given. Residual or recurrent tumors during
follow-up were resected (second or a third craniotomy) if
they showed radiological progression or when they caused
symptoms. Operative morbidity, determined after first,
second, and third surgery, was defined as any complication
leading to symptoms or to unpredicted intervention within
30 days postoperatively, surgical mortality as death within
30 days postoperatively. Complications were classified
into seven groups: none, neurological, endocrinological,
infectious, cerebrospinal fluid (CSF) disturbances, post-
operative hematoma, and other. These complications were
dichotomized into short-term (resolved when the patient
was discharged) and long-term (causing the patient’s death
or permanent disability at time of discharge). We specified
the endocrinological complications for different tumor
locations. In cases of CSF disturbances, shunt dependency
was classified as a long-term complication. Causes of
postoperative hematoma and their consequences were
analyzed by reviewing the surgical reports. For all
deceased patients, the cause of death was established.
Statistical analysis Patients who had undergone surgery for
at least 6 months before the closure of the study were
included for survival analysis. Since WHO classification
and the extent of surgical resection are both associated with
survival [14, 22], we analyzed our survival data using a
Log Rank trend test. Separate Kaplan–Meir curves were
made to visualize survival functions. All analyses were
conducted with statistical software (SPSS 15.0).
Literature review
A literature search of the National Library of Medicine
database (Pubmed; 1960–the present) was conducted in
May 2009, using subject headings (MeSH) and keywords
and limited to human studies. The terms “Brain Neo-
plasms,” “Pediatrics,” “Outcome Assessment (Health
Care),” “Mortality,” “Morbidity,” “Neurosurgery,” and “Post-
operative Complications”were used. Publications written in a
language other than English, Dutch, French, or German were
excluded, as were abstracts, editorials, letters, comments, or
publications before 1960. The abstracts were reviewed, and
articles unrelated to the specific topic were excluded.
Duplicate references, as well as redundant publications, were
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discarded. Using these research criteria, all studies considered
eligible were retrieved, and the final selection was based on
the full article. To identify additional eligible studies, the
reference lists were also screened for journal articles. An
analysis of the published studies concerning surgical morbid-
ity and mortality for pediatric brain tumors was performed.
The data extraction included the following parameters: (1)
year of publication and author, (2) number of reported
patients, (3) reported surgical morbidity and mortality, (4)
types of surgery studied, (5) histopathological types and
location of tumors diagnosed, (6) extent of resection, and (7)
duration of follow-up.
Results
Patient characteristics
There were 70 boys and 51 girls, for a male-to-female ratio
of 1.4:1. The mean age at the time of first surgery was
8.2 years (range 0–17.9; Fig. 1). All 121 patients underwent
primary surgery, 14 patients had a second surgery, and two
patients underwent a third surgery (for a total of 137
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Fig. 2 Specification and number of neurological complications after
first surgery. ICP intracranial pressure
Histopathological diagnosis Total
resection
Subtotal
resection
Partial
resection
WHO N
Astrocytic tumors (41%) 26 14 9 I 34
II 6
III 2
IV 7
Embryonal tumors (20%) 18 5 1 IV 24
Tumors of the sellar region (9%) 9 2 – I 11
Ependymal cell tumors (7%) 7 2 – II 7
III 2
Oligodendroglial tumors (5%) 1 5 – II 4
III 2
Nonmeningothelial tumors of the meninges (5%) 5 1 – I 6
Choroid plexus tumors (3%) 3 1 – I 3
II 1
Neuronal and mixed neuronal–glial tumors (2%) 3 – – I 3
Cysts and tumor-like lesions (2%) 3 – – I 3
Germ cell tumors (2%) 2 – – II 1
III 1
Pineal tumors (1%) – 1 – IV 1
Metastatic tumors (1%) 1 – – IV 1
Tumors of the meninges (1%) 1 – – I 1
Unclassified tumor (1%) 1 – – 1
N=80 N=31 N=10 N=121
Table 1 Summary of 121 cases
with respect to diagnosis, extent
of surgery, and WHO
classification
Age at first surgery
16%
54%
30%
 0-3 years
 4-11 years
 12-18 years
Fig. 1 Age distribution at presentation of children with a brain tumor
(N=121; mean age=8.2 years)
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operations). Of all 121 primary surgical procedures, 80
(66%) were total resections, 31 (26%) subtotal resections,
and ten (8%) partial resections. Reasons for partial removal
of tumors were nine times the unfavorable pathology/
anatomy of the tumor (e.g., brain stem invasion or severe
blood loss) and once for technical reasons (deficient
neuronavigation because of patient’s dental brackets). In
general, reasons for subtotal removal were unfavorable
anatomy/pathology of the tumor. A summary of the 121
cases with regard to the histopathological diagnosis, extent
of resection, and WHO classification is given in Table 1.
The tumor locations were as follows: supratentorial/right or
left hemisphere/ventricle, 47; cerebellum, 21; brain stem,
18; fourth ventricle, 16; sellar/suprasellar/third ventricle,
ten; thalamus/basal nuclei, seven; cerebellopontine angle,
one; and pineal gland, one.
Operative morbidity after first surgery
After first surgery in 121 patients, 38/121 patients (31%) had
an uneventful postoperative period. In the remaining 83
patients (69%), the distribution of complications was as
follows: 53/121 (44%) neurological complications, 27/121
(22%) endocrinological disturbances, 25/121 (21%) infectious
complications, 21/121 (17%) CSF disturbances, 5/121
(4%) postoperative hematomas, and 21/121 (17%) other
complications. Multiple complications could occur in one
single patient.
Fig. 3 Specification, number,
and tumor location of short-term
endocrinological complications
after first surgery
Fig. 4 Specification, number,
and tumor location of long-term
endocrinological complications
after first surgery
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Of the 53 neurological complications, 23 (19%) were
still present at discharge and classified as long-term. In
Fig. 2, all neurological complications are specified.
Operative endocrinological complications included dia-
betes insipidus, panhypopituitarism, hypothyroidism, hypo-
and hypercortisolism, hypokalemia, hypernatremia, and
cerebral salt wasting. Except for patients with panhypopi-
tuitarism and hypothyroidism, all endocrinological compli-
cations were short-term. In cases of panhypopituitarism and
hypothyroidism, patients still have hormone replacement
therapy, and these complications are therefore classified as
long-term. The endocrinological complications were seen in
three tumor locations: sellar/suprasellar/third ventricle,
brain stem, and supratentorial/right or left hemisphere/
ventricle (Figs. 3 and 4).
The surgical infectious complications consisted of
meningitis, urinary tract infections, and wound infections
and were all short-term. One patient (3 years old) with a
supratentorial glioblastoma multiforme developed a bone
flap infection, which was removed. Shortly after this was
resolved, the neurological status worsened, and the
patient died 2 months later due to rapid tumor progres-
sion and leptomeningeal metastases before discharge was
possible.
Of all 21 CSF disturbances, only four (19%) patients
turned out to be shunt-dependent; other CSF disturbances
were CSF leaks or postoperative pseudomeningoceles,
which could be resolved by temporary drainage or
compression bandage.
In five cases, a postoperative hematoma occurred. One
patient had a postoperatively discovered epidural hematoma
caused by a temporal bone fracture due to using the
Mayfield clamp. This patient needed a second emergency
surgery to remove the hematoma and made an uneventful
recovery. In another patient, the postoperative hematoma
was located in the brain stem and caused brain stem
dysfunction. After referral to a rehabilitation center, the
patient’s condition improved considerably (able to walk
independently, talking fluently). In the other three cases, a
hematoma was found on postoperative imaging and was
treated by drainage.
Operative morbidity after second surgery
After second surgery in 14 patients, 7/14 (50%) patients had
an uneventful postoperative period. In the other seven
patients (50%), the distribution of complications was as
follows: 11/14 (79%) neurological complications, 1/14 (7%)
endocrinological disturbance, 1/14 (7%) CSF disturbance,
and 1/14 (7%) other complication. Again, multiple compli-
cations could occur in one single patient.
In Fig. 5, the neurological complications, which were all
long-term, are specified.
The sole endocrinological complication was a short-term
diabetes insipidus. The patient with a CSF disturbance
became shunt-dependent. One patient developed a persistent
headache, which was classified as “other complication.”
A summary of the postoperative complications after first
and second surgery is shown in Table 2. The distribution of
complications among the patients is presented in Table 3.
Operative morbidity after third surgery
There were two tertiary operations. The first patient
(6 years old) had a malignant choroid plexus papilloma.
After the third craniotomy for recurrent disease, the patient
was discharged without any postoperative neurological
deficits. At follow-up, a slight hemiparesis on the right
side and periods of epileptic insults were observed. The
hemiparesis worsened, and a severe dyspraxia is present.
The second patient (6 years old) had an embryonal tumor.
A postoperative partial epileptic seizure occurred, after
which, a long-term speech disturbance and visual deficits
on the right side remained. During follow-up, the tumor
recurred despite a long period of treatment with chemother-
apy. There were no curable options, and 2 months after
following the GEMOX regimen (gemcitabine plus oxaliplatin
combination), the patient died.
In short, the postoperative morbidity after third surgery
amounted to one out of two patients; all were neurological
complications.
Operative mortality
One patient (4 days old) died within 30 days after first
surgery, resulting in a surgical mortality of 0.8%. This
patient was diagnosed with an astrocytoma WHO grade IV.
During surgery, because of the size of the tumor, the brain
collapsed, despite careful retraction, and although blood
loss had not been severe, suddenly cardiac arrest occurred.
Neurological complications 
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Fig. 5 Specification and number of neurological complications after
second surgery
Childs Nerv Syst (2010) 26:1583–1592 1587
Resuscitation was unsuccessful. The cause of death was
defined as central deregulation.
Survival
At the closure of the study, 23 (19%) of the 121 patients had
died: 21 patients due to tumor progression, one perioper-
atively, and one of a combined viral pneumonia (H. influenza
type B and adenovirus) and ARDS (Table 4). The total
cumulative survival is seen in Fig. 6.
The results from the Log Rank trend test showed thatWHO
classification and grade of tumor resection were significantly
related to survival (p<0.001; p=0.016; Figs. 7 and 8).
Literature review
The literature search resulted in ten articles concerning
operative mortality after surgery of pediatric brain tumors.
These data, including those of the current study, are
summarized in Table 5.
Discussion
Previous reports on morbidity and mortality rates after
craniotomies for brain tumors in children have (1) been
limited to studying single entity tumors such as pilocytic
astrocytomas, craniopharyngiomas, medulloblastomas, or
brainstem tumors; (2) excluded patients undergoing repeat
surgery; and (3) included large numbers of patients from
renowned, large, high-volume, pediatric neurosurgical
centers [7–9, 12, 16, 18]. The current study concerns the
surgical morbidity and mortality rates for all pediatric brain
tumor patients combined and treated in one tertiary referral
center between 1999 and 2007. The results are discussed in
the light of the present literature.
Quality assessment
Outcome indicators of patient care in pediatric neurosur-
gery are hardly available, and a review of the literature
shows remarkable differences in the reported results.
Comparing the outcome data of different studies is difficult
because of the heterogeneity of criteria used when selecting
the type of surgery for each patient, when evaluating the
extent of resection, or when defining surgical complications
and their severity [4]. The reported morbidity and mortality
rates for single tumor entities from large, high-volume
centers are not necessarily representative for all those
patients treated worldwide in less specialized, low-volume
centers, by specialists with far less extensive experience. In
addition, patients and their parents, and even our external
stakeholders, are increasingly demanding their right to be
informed about the actual morbidity and mortality rates
obtained in the institution actually providing the care. To
meet this demand, it is necessary for all care providers to
audit their own results on a regular basis and to compare
these with reported figures from comparable institutions.
With this information, they can establish a prognosis not
only in terms of survival and outcome but also in terms of
treatment-related morbidity and mortality. This provides
clinicians, parents, and policy makers with more accurate
and reliable information upon which decisions can be
based [2].
In several fields in surgery, it is well recognized that
so-called high-volume hospitals and high-volume surgeons
lead to lower mortality and morbidity rates and a better
outcome for the patients [6, 19]. It is therefore paramount
for smaller centers to not only compare their results with
similar institutions but also with the results obtained in
these large centers. The VUmc has a pediatric neurosurgery
Type of
complication
Complications after first
surgery (N patients=121)
Percent Complications after second
surgery (N patients=14)
Percent
None 38 31 7 50
Neurological 53 44 11 79
Endocrinological 27 22 1 7
Infectious 25 21 0 0
CSF disturbances 21 17 1 7
Hematoma 5 4 0 0
Other 21 17 1 7
Table 2 Summary of
complications after first
and second surgery
Table 3 Number of complications per patient after first and second
surgery
Number of
complications
N (patients)
after first surgery
N (patients) after
second surgery
0 38 7
1 41 4
2 23 1
3 13 1
4 4 0
5 2 1
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unit that serves as one of the eight tertiary referral
centers in The Netherlands (total population 16,645,313,
of which, 1,427,297 (17.6%) are 0–14 years) with
subsequently a fairly modest volume of pediatric brain
tumor patients.
Morbidity rates
Neurological morbidity after first surgery was 44% in our
study, which is generally in line with the 33% and 54%
neurological complications in recent studies [16, 22].
The rates of endocrinological complications after
craniotomy vary greatly in the literature. An explanation for
these differences can be found in the fact that endocrinological
complications are typically reported in series of (supra)sellar
tumors. Comparison with these percentages is not reasonable
as our study included only a small number of (supra)sellar
tumors.
The prospectively established postoperative wound
infection rate in the neurosurgical department of the VUmc
(adults and children combined) is lower than 5% (data not
shown). The high percentage of 21% short-term infection
after first surgery found in this present retrospective study
includes all infectious complications after surgery, not only
wound infections. The majority of these were caused by
temporary external CSF diversion, which was often
complicated by transient meningitis. This warrants further
investigation and improvement. The rate of postoperative
wound infections in this cohort was less than 2% (two out
of 137) and compares favorably to published rates [9, 21].
All temporary and permanent CSF disturbances were
registered as surgical complications. A large proportion of
the permanent disturbances, however, can be attributed to
the nature and location of the brain tumor itself. The rate of
long-term shunt dependency in this study was low compared
to other surgical series, but comparison is difficult in these
mixed case series [1, 21, 22]. A recent study of a mixed
cohort (pediatric posterior fossa tumors) of two institutions
combined showed a considerable difference (31% vs 19%)
in the rate of permanent CSF diversion at 6 months [15].
Table 4 Summary of 23 deceased patients regarding gender, age, year of surgery, diagnosis, and cause of death
Sex Age (years)a Year of surgery Diagnosis Observation time (months)b Cause of death
F 8.9 2000 Astrocytic tumor (WHO 1) 21 Tumor progression
F 2.8 2000 Astrocytic tumor (WHO III) 17 Tumor progression
F 13.5 2004 Astrocytic tumor (WHO III) 17 Tumor progression
M 7.6 2005 Astrocytic tumor (WHO IV) 2 Tumor progression
M 4.3 2002 Astrocytic tumor (WHO IV) 10 Tumor progression
F 0.9 1999 Astrocytic tumor (WHO IV) 5 Tumor progression
F 8.9 2003 Astrocytic tumor (WHO IV) 12 Tumor progression
F 4.0 2000 Astrocytic tumor (WHO IV) 7 Tumor progression
M 3.7 2006 Astrocytic tumor (WHO IV) 2 Tumor progression
F 14 2001 Astrocytic tumor (WHO IV) 23 Tumor progression
F 0.0 2004 Astrocytic tumor (WHO IV) – Collapsed brain, central
deregulation, cardiac arrest
M 11.0 2000 Oligodendroglial tumor (WHO II) 11 Tumor progression
F 13.1 2003 Oligodendroglial tumor (WHO III) 9 Tumor progression
M 1.6 2002 Ependymal cell tumor (WHO II) 16 Tumor progression
M 3.5 1999 Ependymal cell tumor (WHO II) 19 Tumor progression
F 2.7 1999 Ependymal cell tumor (WHO II) 19 Tumor progression
M 0.5 1999 Pineal parenchyma tumor 17 Tumor progression
M 13.5 2004 Embryonal tumor (WHO IV) 8 Tumor progression
M 2.0 2002 Embryonal tumor (WHO IV) 3 Tumor progression
F 2.6 2004 Embryonal tumor (WHO IV) 2 Tumor progression
M 10.8 2000 Embryonal tumor (WHO IV) 18 Tumor progression
M 2.0 2003 Embryonal tumor (WHO IV) 2 Combined viral pneumonia
and ARDS
F 9.3 1999 Embryonal tumor (WHO IV) 8 Tumor progression
ICP intracranial pressure, CNS central nervous system, ARDS acute respiratory distress syndrome
a At time of tumor resection
b Time between tumor surgery and death
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The rates of other complications were all relatively low
and comparable with other studies [1, 7, 9, 16, 21].
Mortality rates
In the literature, overall mortality varies from 5% to 40%
[9, 13, 18, 22]. As stated earlier, comparison of series with
a different case mix is difficult, as different tumor types will
influence overall survival. This is clear when comparing
pilocytic astrocytomas with, e.g., brainstem tumors. In
addition, the mean age of the studied population in
published series also differs considerably.
Literature review
In the literature, overall surgical morbidity rates vary from
10% to 54%. The rates highly depend on the nature of the
tumors studied, as morbidity for brainstem tumors or optic
Fig. 6 Total cumulative
survival
Fig. 7 Cumulative survival
according to the WHO
classification
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gliomas will obviously be higher than morbidity for
hemispherically located tumors [2, 7, 16, 18, 21, 22].
In addition, the percentages can differ due to different
inclusion criteria for different complications. For example,
sometimes the natural history of a disease is included as a
complication, as our study defined any event that caused
postoperative symptoms or led to an unexpected intervention
as a complication. In addition, no detailed information about
surgical procedures performed in other hospitals was
available for the current study. As a result, some of the
patients who underwent surgery in our hospital for the first
time had been operated earlier in another institution.
Obviously, this would have negatively influenced morbidity
rates. It is understandable that the overall morbidity rate in
the current study differs from other studies due to strict
application of our criteria. Nevertheless, we conclude that the
overall surgical morbidity rate of 69% (83 complications in
121 patients) after first surgery and 50% (seven complications
in 14 patients) after second surgery are comparable to other
mixed series [7–9, 12, 16, 18].
Surgical mortality rates for brain tumors in patients
(0–18 years) also vary greatly and range from 0% to 20%
Table 5 Operative mortality after surgery of pediatric brain tumors in the literature
Year Author Operated
between years
N Surgical
mortality (%)
TR (%) SR (%) PR (%) Tumors
1994 Sinson 1977–1991 10 20 – – – Giant cell astrocytomas
1996 Dirven 1969–1990 73 1 – – – Pilocytic astrocytomas
1997 Medlock 1988–1994 20 0 40 45 15 Optic chiasm astrocytomas
2002 Due-Tonnessen 1960–2001 110 9 72 28 – Astrocytomas
2004 Gonc 1969–1999 66 11 31 52 17 Craniopharyngioma
2006 Sandri 1995–2003 17 6 24 41 35 Focal brainstem
1999 Albright 1996–1998 100 1 – – – Mixed
2003 Smith 1988–2000 4712 2 – – – Mixed
2004 Akay 1995–2002 27 0 59 33 8 Mixed
2004 Young 1988–1999 16 7 7 57 36 Mixed
2009 Neervoort 1999–2007 121 1 66 26 8 Mixed
TR total resection, SR subtotal resection, PR partial resection
Fig. 8 Cumulative survival of
patients according to the extent
of tumor resection
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[1, 2, 7–9, 16, 18]. The largest series by Smith et al. in 4,712
admissions (329 hospitals, 480 identified surgeons) for
pediatric brain tumor craniotomy found that the mortality rate
was 2.3% at the lowest-volume-quartile hospitals (four or
fewer admissions annually) compared with 1.4% at the
highest-volume-quartile hospitals (more than 20 admissions
annually) [19]. The surgical mortality in the current study
was 0.8%, which is comparable to the lowest rates reported
for highest-quartile hospitals.
Conclusion
The aim of the study was to perform an internal quality
control of the pediatric neurosurgical department of the
VUmc (Amsterdam, The Netherlands) and to expose the
quality of the surgery by reporting the surgical mortality
and morbidity of all children (0–18 years) surgically treated
for an intracranial brain tumor from January 1999 to August
2007. The overall surgical morbidity rate was 69% after
first surgery, 50% after second surgery, and one out of two
after third surgery. The surgical mortality rate was 0.8%
with an overall mortality rate of 19% during long-term
follow-up (January 1999–August 2007).
We encourage other neurosurgical centers to collect and
analyze their own data. This can serve as a basis for
comparison with other pediatric neurosurgical centers and
should eventually lead to an improvement of pediatric
neurosurgical practice and patient care.
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